ATI CMS Pharmacology Proctored Exam
60 Actual Questions with Verified Answers | 100% Accuracy
Nursing Pharmacology Certification | 2026/2027 Edition | Graded A+
Total Questions: 60 | Cognitive Distribution: 25% Recall, 55% Application, 20% Analysis (NGN Clinical Judgment) | Format: 70%
Scenario-Based, 20% Direct Recall, 10% NGN Case Analysis
Aligned with 2026-2027 ATI CMS Pharmacology Proctored Exam blueprints, NCLEX-RN/PN standards, and current pharmacology
guidelines including NGN clinical judgment framework integration.
Secti
Content Domain Questions
on
1 Pharmacokinetics and Pharmacodynamics Q1-Q8
2 Medication Administration and Safety Q9-Q15
3 Cardiovascular Pharmacology Q16-Q25
4 Endocrine and Metabolic Pharmacology Q26-Q33
5 Neurological and Psychiatric Pharmacology Q34-Q42
6 Antimicrobial and Anti-inflammatory Pharmacology Q43-Q50
7 Gastrointestinal, Respiratory, and Genitourinary Pharmacology Q51-Q56
8 Comprehensive NGN Case Scenarios Q57-Q60
Section 1: Pharmacokinetics and Pharmacodynamics (Absorption, Distribution, Metabolism,
Excretion, Half-Life, Steady State, Receptor Theory)
Questions 1-8 | Cognitive focus: half-life calculations, first-pass effect, therapeutic index, CYP450 interactions, protein binding, receptor
theory, route-dependent bioavailability.
Q1: A patient is prescribed an oral medication with a known half-life of 12 hours. The nurse is teaching the
patient about steady state. How many days will it take for the medication to reach steady state, assuming no
loading dose is administered?
A. 1 day (2 half-lives).
B. 2 days (4 half-lives). [CORRECT]
C. 3 days (6 half-lives).
D. 5 days (10 half-lives).
Correct Answer: B
Rationale: Steady state is achieved in approximately 4 to 5 half-lives. With a half-life of 12 hours, 5 half-lives equal 60 hours,
or approximately 2.5 days; 4 half-lives equal 48 hours, or 2 days. ATI pharmacology emphasizes the 4-5 half-life rule for
steady state. Options A, C, and D reflect common miscalculations students make when confusing half-life count with days.
Q2: A graduate nurse is preparing to administer a medication orally and recalls that the first-pass effect
significantly reduces drug bioavailability. Which route would bypass the first-pass effect to the greatest extent?
A. Oral (PO).
Nursing Pharmacology Certification - Verified Answers Page 1
,ATI CMS Pharmacology Proctored Exam - 2026/2027 | 60 Questions | Graded A+ NGN Integrated | NCLEX Aligned
B. Sublingual. [CORRECT]
C. Enteric-coated oral.
D. Sustained-release oral.
Correct Answer: B
Rationale: The first-pass effect occurs when a drug is absorbed through the gastrointestinal tract and transported via the
portal vein to the liver, where significant metabolism reduces bioavailability. Sublingual administration allows drug
absorption directly into the systemic circulation, bypassing the liver. Oral, enteric-coated, and sustained-release
formulations all undergo first-pass metabolism. ATI principles emphasize route selection as a key pharmacokinetic
consideration.
Q3: A patient receiving a medication with a narrow therapeutic index is being discharged. Which statement by
the patient indicates a correct understanding of this concept?
A. A narrow therapeutic index means the medication is very safe at any dose.
B. A narrow therapeutic index means the difference between a therapeutic dose and a
toxic dose is very small, requiring close serum monitoring. [CORRECT]
C. A narrow therapeutic index means I can take extra doses if I miss one.
D. A narrow therapeutic index means the medication works instantly.
Correct Answer: B
Rationale: A narrow therapeutic index indicates a small margin between therapeutic and toxic doses, requiring serum drug
level monitoring (e.g., digoxin, lithium, phenytoin, vancomycin). Options A, C, and D reflect dangerous misunderstandings
that could lead to toxicity. ATI pharmacology stresses the importance of therapeutic drug monitoring for narrow-index
agents.
Q4: A patient is taking warfarin and is newly prescribed fluconazole, a potent CYP450 enzyme inhibitor. The
nurse anticipates which effect on the warfarin therapy?
A. Increased metabolism of warfarin, requiring a higher dose.
B. Decreased metabolism of warfarin, increasing the risk of bleeding and necessitating
INR monitoring and possible dose reduction. [CORRECT]
C. No change in warfarin metabolism or INR.
D. Immediate reversal of warfarin's therapeutic effect.
Correct Answer: B
Rationale: CYP450 inhibitors decrease the metabolism of medications metabolized by those enzymes. Warfarin is
metabolized primarily by CYP2C9; fluconazole inhibits this enzyme, increasing warfarin levels and bleeding risk. ATI
principles emphasize drug interaction recognition, INR monitoring, and dose adjustment when CYP inhibitors are introduced.
Q5: A nurse is explaining drug distribution to a nursing student. Which factor most significantly limits the
distribution of protein-bound medications into target tissues?
A. Patient's heart rate.
B. Plasma protein binding, particularly to albumin, which keeps the drug in the
vascular space and limits free drug availability. [CORRECT]
C. Patient's respiratory rate.
D. Patient's dietary protein intake alone, with no role for albumin.
Correct Answer: B
Rationale: Only the free (unbound) fraction of a drug is pharmacologically active and able to distribute into tissues. Highly
protein-bound drugs (e.g., warfarin, phenytoin, digoxin) are limited in distribution by albumin binding. In hypoalbuminemia,
Nursing Pharmacology Certification - Verified Answers Page 2
, ATI CMS Pharmacology Proctored Exam - 2026/2027 | 60 Questions | Graded A+ NGN Integrated | NCLEX Aligned
free drug increases, raising toxicity risk. ATI emphasizes that protein binding is a key determinant of distribution and free
drug levels.
Q6: An elderly patient with reduced hepatic function is prescribed a medication that undergoes extensive
hepatic metabolism. Which pharmacokinetic change should the nurse anticipate?
A. Increased drug clearance requiring a higher dose.
B. Decreased drug metabolism leading to drug accumulation, prolonged half-life, and
need for dose reduction. [CORRECT]
C. No change in drug metabolism.
D. Immediate elimination of the drug through the kidneys unchanged.
Correct Answer: B
Rationale: Reduced hepatic function decreases first-pass metabolism and overall drug clearance, prolonging half-life and
increasing the risk of accumulation and toxicity. Older adults are especially vulnerable. ATI pharmacology principles
emphasize dose adjustment and enhanced monitoring for hepatically metabolized drugs in older adults and those with liver
impairment.
Q7: A nurse is teaching a patient about receptor theory and explains that an antagonist medication produces its
effect by which mechanism?
A. Activating the receptor to produce a maximal response.
B. Binding to the receptor without activating it, thereby blocking the action of
endogenous ligands or agonists. [CORRECT]
C. Increasing the number of available receptors on the cell surface.
D. Speeding up the metabolism of endogenous neurotransmitters.
Correct Answer: B
Rationale: An antagonist binds to a receptor without activating it, blocking endogenous ligands or agonist medications
from exerting their effect (e.g., naloxone at opioid receptors). Agonists activate receptors to produce a response. ATI
principles stress the clinical importance of antagonists in overdose reversal and therapeutic blockade.
Q8: A patient receiving a medication intravenously asks the nurse why the onset of action is faster than when
taking the same medication orally. The nurse's best response is based on which pharmacokinetic principle?
A. Oral medications bypass absorption entirely.
B. Intravenous administration places the drug directly into the systemic circulation,
bypassing absorption barriers and first-pass metabolism for immediate bioavailability.
[CORRECT]
C. Oral medications are absorbed more slowly because they require digestion by
stomach acid.
D. Intravenous medications are metabolized faster by the liver.
Correct Answer: B
Rationale: Intravenous administration delivers 100% of the drug directly into the systemic circulation, bypassing absorption
barriers and first-pass hepatic metabolism, producing immediate onset. Oral medications must be absorbed and undergo
first-pass metabolism, delaying and reducing effect. ATI pharmacology stresses route-dependent bioavailability and onset.
Nursing Pharmacology Certification - Verified Answers Page 3